SOUTH SAN FRANCISCO, Calif. & SINGAPORE--(BUSINESS WIRE)--Counsyl, a DNA testing and genetic counseling service, today announced an expanded agreement with Angsana Molecular & Diagnostics Laboratory, a multinational laboratory services company, to commercialize Counsyl’s proprietary expanded carrier screening (ECS) test in Hong Kong, an influential market for advanced medical care throughout Asia.
Counsyl’s ECS leads the industry in identifying the approximately one in 65 couples of East Asian descent who are at-risk of passing serious and actionable conditions to their children. This information allows couples to make informed decisions for conditions that can be passed down to children. Angsana’s expansive network of clinicians will now be able to offer this test to their patients. All samples will be processed at Counsyl’s CLIA-certified automated clinical laboratory in South San Francisco, California.
To help clinicians learn more about the benefits of offering ECS to patients, Angsana and Counsyl will host two joint events for physicians on July 11 and 13 at Central and Tsimshatsui, Hong Kong. The sessions will feature presentations and discussion sessions with Mr. Kenny Wong, MS, CGC, clinical product director, carrier screening at Counsyl. Both lectures will be chaired by Hong Kong obstetrician & gynecologist specialists in reproductive medicine and will be accredited Continuing Medical Education (CME) points by the Hong Kong College of Obstetricians & Gynaecologists (HKCOG).
“This expansion is part of our larger strategic effort to increase global access to comprehensive, clinically relevant and affordable testing in women’s health,” stated Matthew J. Meyer, Counsyl’s senior vice president of corporate development. “Angsana’s extensive clinical partnerships in Hong Kong will help to quickly bring Counsyl’s industry-leading expanded carrier screening offering to a new patient population.”
“Angsana, which operates two College of American Pathologists (CAP) accredited laboratories in Singapore and Hong Kong, is most committed to improving healthcare through utilization of molecular information to tailor treatment to the needs and characteristics of individual patients,” says Dr. Chris Tan, chief executive officer and founder of Angsana Molecular & Diagnostics. “We chose Counsyl’s panel because of its coverage of serious, clinically actionable and prevalent diseases, which is aligned to our mission of empowering doctors and patients in making better informed decisions.”
Counsyl is a DNA testing and genetic counseling service committed to helping patients understand their DNA and how it can inform important health decisions. Whether it’s starting a family or evaluating risk for cancer, Counsyl's DNA tests provide patients with early awareness about genetic conditions, so they can live informed and prepare for the future. Counsyl has screened more than 750,000 patients and served more than 10,000 healthcare professionals. For more information, visit www.counsyl.com. Sign up for news announcements from Counsyl at subscribe.counsyl.com.
About Angsana Molecular & Diagnostics Laboratory
Angsana Molecular & Diagnostics Laboratory specializes in developing premium molecular diagnostic assays, serving the following four medical areas that have the largest impact in Asian population: allergy and molecular allergology, fetal maternal health, molecular oncology and pharmacogenetics. Through analysis of medical conditions at a molecular level, combined with clinical consultation by board-certified medical geneticists and sub-specialty trained pathologists, Angsana empowers clinicians and patients to make better informed clinical decisions and improve the quality of patient care. Strategically located in the center of Asia with multi-laboratory operations in Singapore, Hong Kong and Malaysia, Angsana Molecular & Diagnostics Laboratory is dedicated to serving the Asian community with fast and more affordable services within easy reach. For more information, visit www.angsanadx.com.